| 000 | 01365 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517094053.0 | ||
| 264 | 0 | _c20161216 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a2052-4463 | ||
| 024 | 7 |
_a10.1038/sdata.2016.27 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeifman, N | |
| 245 | 0 | 0 |
_aA patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials. _h[electronic resource] |
| 260 |
_bScientific data _cMay 2016 |
||
| 300 |
_a160027 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xstandards |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitoxantrone _xpharmacology |
| 650 | 0 | 4 |
_aPrednisone _xpharmacology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTaxoids _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aButte, A J | |
| 773 | 0 |
_tScientific data _gvol. 3 _gp. 160027 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sdata.2016.27 _zAvailable from publisher's website |
| 999 |
_c26005588 _d26005588 |
||